These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32580137)

  • 1. Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes.
    Liu M; An H; Zhang Y; Sun W; Cheng S; Wang R; Wang X; Feng L
    EBioMedicine; 2020 Jul; 57():102831. PubMed ID: 32580137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer demethylation-regulated gene score identified molecular subtypes, inspiring immunotherapy or CDK4/6 inhibitor therapy in oesophageal squamous cell carcinoma.
    Gao W; Liu S; Wu Y; Wei W; Yang Q; Li W; Chen H; Luo A; Wang Y; Liu Z
    EBioMedicine; 2024 Jul; 105():105177. PubMed ID: 38924839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
    Li S; Liu Z; Chen Q; Chen Y; Ji S
    Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
    Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
    Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic profiling identifies PDLIM2 as a novel prognostic predictor for oesophageal squamous cell carcinoma (ESCC).
    Song G; Xu J; He L; Sun X; Xiong R; Luo Y; Hu X; Zhang R; Yue Q; Liu K; Feng G
    J Cell Mol Med; 2019 Aug; 23(8):5751-5761. PubMed ID: 31222932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
    Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Bioinformatics Analysis Identifies Hub Genes Associated with the Pathogenesis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Zhang H; Zhong J; Tu Y; Liu B; Chen Z; Luo Y; Tang Y; Xiao F; Zhong J
    Biomed Res Int; 2019; 2019():2615921. PubMed ID: 31950035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations.
    Wang F; Yan Z; Lv J; Xin J; Dang Y; Sun X; An Y; Qi Y; Jiang Q; Zhu W; Li Y; Li A; Guo X
    Neoplasia; 2019 Jun; 21(6):571-581. PubMed ID: 31048097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Zhang F; Xu C; Li X; Zeng H; Su J; Huang J; Xu Y; Lu S; Hou Y
    Cancer Genet; 2023 Nov; 278-279():1-8. PubMed ID: 37556965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 16. miR-877-3p as a Potential Tumour Suppressor of Oesophageal Squamous Cell Carcinoma.
    Fukuda T; Baba H; Okumura T; Kanda M; Akashi T; Tanaka H; Miwa T; Watanabe T; Hirano K; Sekine S; Hashimoto I; Shibuya K; Hojo S; Yoshioka I; Matsui K; Kodera Y; Fujii T
    Anticancer Res; 2023 Jan; 43(1):35-43. PubMed ID: 36585184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
    Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
    Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
    Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR
    BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
    Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
    J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.